KIMBERLY BEHANA: Open Payments
NPI 1003801168 · BELLE VERNON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 45 payments from 18 companies in 2025. Trend: 2023 $120 · 2024 $240 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $349 |
| Abbott Laboratories | 4 | $173 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: Ozempic, XACT, Wegovy, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, ELIQUIS, GARDASIL 9, JARDIANCE.
Industry payments across PA — which companies pay providers there.
